Impact of Cytogenetics on Outcome of De Novo and Therapy-Related AML and MDS after Allogeneic Transplantation

Abstract Cytogenetics has an important impact on the prognosis of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) for acute myelogenous leukemia (AML) or myelodysplastic syndromes (MDS). However, it is unclear whether currently accepted cytogenetic risk groups, which we...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biology of blood and marrow transplantation 2007-06, Vol.13 (6), p.655-664
Hauptverfasser:	Armand, Philippe, Kim, Haesook T, DeAngelo, Daniel J, Ho, Vincent T, Cutler, Corey S, Stone, Richard M, Ritz, Jerome, Alyea, Edwin P, Antin, Joseph H, Soiffer, Robert J
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Acute myelogenous Leukemia Adolescent Adult Allogeneic stem cell transplantation Cytogenetics Female Hematology, Oncology and Palliative Medicine Hematopoietic Stem Cell Transplantation - adverse effects Humans Leukemia, Myeloid - etiology Leukemia, Myeloid - genetics Leukemia, Myeloid - mortality Leukemia, Myeloid - therapy Male Middle Aged Multivariate Analysis Myelodysplastic syndrome Myelodysplastic Syndromes - etiology Myelodysplastic Syndromes - genetics Myelodysplastic Syndromes - mortality Myelodysplastic Syndromes - therapy Prognosis Recurrence Secondary leukemia Survival Rate Therapy-related disease Transplantation, Homologous Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!